MedTrace Logo

Compare the Pharmacokinetics and Safety of CKD-391

NCT04354987 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2020-04-21

No results posted yet for this study

Summary

phase I clinical trial to compare the pharmacokinetics and safety of CKD-391 with co-administration of D090 and D337 in healthy adult volunteers

Conditions

  • Hyperlipidemias

Interventions

DRUG

CKD-391 10/10mg

Drug T: CKD-391 10/10mg(Other Name: Test Drug)

DRUG

D090, D337

D090 and D337 co-administration(Other Name: Reference drug)

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    collaborator OTHER

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-30
Primary Completion
2020-01-09
Completion
2020-01-09

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04354987 on ClinicalTrials.gov